Hogan & Hartson LLP

Industry:	Law Firms & Legal Services
Revenues:	$192.7 Million
Employees:	2,222

Description

Hogan & Hartson's telecommunications, media, and technology (TMT) lawyers possess an in-depth understanding of our clients' business, their increasing inter-modal competition and the regulatory environments in which they operate. With the firm's 22 offices worldwide, our TMT practice is among the most interconnected in the world. This global reach allows us to serve clients in industries that are ever more complex, increasingly reliant on cross-border transactions, and frequently subject to regulations at multiple jurisdictional levels.

Find More Jobs

Job Openings

Drivers St. Louis , MO

Driver Aurora , IL

Drivers Carbondale , IL

Drivers Not , MO

Drivers Not , MO

View More Statistics

Site Statistics

Monthly Unique Visitors:	10,499
Site Rank:	147,941
Trust Rating:	Neutral
Stats by

News Archive

Coldwater Creek Announces Management Change. Investment Weekly News; 12/5/2009 ...1999. Prior to joining Coldwater Creek, Mr. Hayes spent 17 years in private law practice, most recently with Hogan & Hartson, LLP. Dennis Pence, Chairman and Chief Executive Officer, said, "We are pleased to have John step in as interim... ...more

Leading Attorneys Band Together to Advance Corporate Ethics Dialogue Through Ethisphere-Corpedia Joint Committee on Business Ethics. Business Wire; 11/23/2009 ...Joint Committee," said Stuart Altman, Partner at Hogan & Hartson LLP. "By virtue of our membership, my fellow Committee...representatives from 10 law firms: * Stuart Altman, Partner -Hogan & Hartson LLP * Gary Anderson, Shareholder -Greenberg Traurig... ...more

Study results from Hogan & Hartson, LLP broaden understanding of oncology. Medical Letter on the CDC & FDA; 10/4/2009 According to recent research published in the American Journal of Public Health, "I examined the relationship between the Food and Drug Administration's (FDA's) use of special regulatory designations and the frequency with which labels of oncology drugs are revised to explore how the FDA's ...more